flexghost. on Nostr: Amazing. A personalized mRNA cancer vaccine just succeeded in a 1,137-patient Phase 3 ...
Amazing.
A personalized mRNA cancer vaccine just succeeded in a 1,137-patient Phase 3 melanoma trial…
Each vaccine is built from mutations in that individual patient’s tumor
Earlier results have now held for 5 years: 49% lower risk of recurrence or death / 59% lower risk of distant metastasis or death
Waiting on full Phase 3 data but something that seemed like a far off dream could be a reality!
Published at
2026-08-19 17:51:33 UTCEvent JSON
{
"id": "7c29c1704f21bd85eeebb2bd0409901a906cd7671d64ef27fd06c7bcadc85627",
"pubkey": "2afb2aa0356d751ca6bb95d82c879a2838997802fb8bce0b405bbf586d638d8d",
"created_at": 1787161893,
"kind": 1,
"tags": [
[
"imeta",
"url https://files.mastodon.social/media_attachments/files/117/123/432/759/574/183/original/bb4b38542c36a1e0.jpeg",
"m image/jpeg",
"dim 1320x2238",
"blurhash UyO4e*j]ozoz~BWBf6j@IpofWVazX9t7WBay"
],
[
"proxy",
"https://mastodon.social/users/flexghost/statuses/117123441836613385",
"activitypub"
],
[
"client",
"Mostr",
"31990:6be38f8c63df7dbf84db7ec4a6e6fbbd8d19dca3b980efad18585c46f04b26f9:mostr",
"wss://relay.ditto.pub"
]
],
"content": "Amazing.\n\nA personalized mRNA cancer vaccine just succeeded in a 1,137-patient Phase 3 melanoma trial…\n\n Each vaccine is built from mutations in that individual patient’s tumor\n\n Earlier results have now held for 5 years: 49% lower risk of recurrence or death / 59% lower risk of distant metastasis or death\n\nWaiting on full Phase 3 data but something that seemed like a far off dream could be a reality!\n\nhttps://files.mastodon.social/media_attachments/files/117/123/432/759/574/183/original/bb4b38542c36a1e0.jpeg",
"sig": "3bcdf698ccab36e81510a7d84ae8aa4a061a4962c2f7f1e810d0823dfe258a71ec427c451cce14c8f68d7ea9d4470f2a191969563ac8bfab523936607216c614"
}
